News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
News
Web & Podcasts
What’s On
Show submenu for What’s On
Webinars
Events
About Us
Show submenu for About Us
Who We Are
Our Contributors
Advertise
Contact
UBI signs Henry Schein as US distribution partner for Xprecia
Imugene opens first Australian site for azer-cel trial
Adisyn Accelerates Graphene Revolution with New ALD Machine for Semiconductor Breakthroughs
Wotso acquires first property in Melbourne
Sigma welcomes the ACCC's decision on Chemist Warehouse
Quickstep Holdings Responds to ASDAM’s Takeover Offer Amid Strengthened Contract Wins
AVITA Medical Reports Strong Q3 Growth with RECELL GO Sales Surge and Prepares for New Product Launches
Archer's miniaturised Biochip gFET design improves foundry readiness
TrivarX’s new AI tool expands patient reach
Recce's Phase II ABSSSI clinical trial advances to final stages
Q&A With Dr David Ali From Memphasys Reproductive Biotechnology (ASX:MEM)
Staff Writers
12 June, 2023
Pharmaceuticals
SHARE
SHARE
Rate video from Staff Writers:
Related Videos & Media on TechInvest
29 September, 2023
Memphasys (ASX:MEM) Investor Webinar - 21 Sept 2023
Watch video
Innovation
3 April, 2023
Memphasys Limited ASX Announcement
Watch video